Zhejiang Wolwo Bio-Pharmaceutical Co. Ltd Financials

Market Capitalization CN¥11.34 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	36.10
Forward PE	27.42
Price to Sales TTM	CN¥12.54
Price to Book MRQ	CN¥4.80
Enterprise to Revenue	11.33
Enterprise to EBITDA	29.82

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	34.52%
Operating Margin	43.05%
Return on Assets TTM	7.30%
Return on Equity TTM	12.59%

Income Statement

Revenue TTM	CN¥904,637,888
Revenue per Share TTM	CN¥1.73
Quarterly Revenue Growth	4.70%
Gross Profit TTM	CN¥808,000,999
EBITDA	CN¥359,667,282
Net Income to Common TTM	CN¥312,291,072
Diluted EPS TTM	CN¥0.60
Quarterly Earnings Growth YoY	1.20%

Balance Sheet

Total Cash MRQ	CN¥1,251,600,896
Total Cash per Share MRQ	CN¥2.39
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	2.05
Current Ratio MRQ	10.09
Book Value per Share MRQ	CN¥4.51

Cash Flow

Operating Cash Flow TTM	CN¥290,904,128
Levered Free Cash Flow TTM	CN¥43,259,784

300357 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	523,584,000
Float Shares	225,010,224
Avg 10 Volume	7,632,726
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	51.46%
% Held by Institutions	12.97%

Stock Price Summary

Beta	0.68
Fifty Two Week Low	CN¥16.32
Fifty Two Week High	CN¥29.21
Fifty Two Week Change	-15.54%
Day 50 MA	CN¥23.17
Day 200 MA	CN¥22.00

Dividends and Splits

Forward Annual Dividend Rate	CN¥0.74
Forward Annual Dividend Yield	3.75%
Trailing Annual Dividend Rate	CN¥0.19
Trailing Annual Dividend Yield	0.94%
Payout Ratio	31.02%
Dividend Date
Ex Dividend Date	2024-07-04
Last Split Factor
Last Split Date	2019-05-08